156 related articles for article (PubMed ID: 11579945)
1. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy.
Tomiyoshi Y; Sakemi T; Ikeda Y; Ohtsuka Y; Nakamura M; Fujisaki T
Intern Med; 2001 Sep; 40(9):862-6. PubMed ID: 11579945
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study.
Liang M; Xiong L; Li A; Zhou J; Huang Y; Huang M; Zhang X; Shi H; Su N; Wei Y; Jiang Z
BMC Nephrol; 2022 Jan; 23(1):40. PubMed ID: 35062886
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
Branten AJ; Klasen IS; Wetzels JF
Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
7. IgA nephropathy with crescents in kidney transplant recipients.
Kowalewska J; Yuan S; Sustento-Reodica N; Nicosia RF; Smith KD; Davis CL; Alpers CE
Am J Kidney Dis; 2005 Jan; 45(1):167-75. PubMed ID: 15696457
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
9. Segmental glomerular necrosis as an active index of IgA nephropathy: a study with 100 serial sections of 128 cases.
Shouno Y; Shimokama T; Sakemi T; Harada A; Yamaguchi M; Watanabe T
Acta Pathol Jpn; 1993 Dec; 43(12):723-9. PubMed ID: 8109250
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
Shoji T; Nakanishi I; Suzuki A; Hayashi T; Togawa M; Okada N; Imai E; Hori M; Tsubakihara Y
Am J Kidney Dis; 2000 Feb; 35(2):194-201. PubMed ID: 10676716
[TBL] [Abstract][Full Text] [Related]
11. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA; Lohavichan V; Hennigar R
Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
[TBL] [Abstract][Full Text] [Related]
12. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
Chen KJ; Cheng CH; Wu MJ; Chen CH; Shu KH
J Chin Med Assoc; 2003 May; 66(5):263-70. PubMed ID: 12908567
[TBL] [Abstract][Full Text] [Related]
13. [Severe proteinuria in IgA nephropathy. Clinicopathological study of 8 cases with 100 serial sections].
Shouno Y; Shimokama T; Sakemi T; Harada A; Watanabe T
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1043-50. PubMed ID: 8230814
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of IgA Nephropathy with Segmental Glomerular Necrosis But without Crescent Formation.
Tan M; Li W; Zou G; Zhang C; Fang J
Am J Nephrol; 2016; 43(5):341-7. PubMed ID: 27166147
[TBL] [Abstract][Full Text] [Related]
15. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
Lai KN; Lai FM; Ho CP; Chan KW
Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
[TBL] [Abstract][Full Text] [Related]
17. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study.
Wang J; Juan C; Huang Q; Zeng C; Liu Z
Nephrol Dial Transplant; 2013 Sep; 28(9):2339-45. PubMed ID: 23787555
[TBL] [Abstract][Full Text] [Related]
19. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
